Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Cancer Genetics, Inc.

TRADE

NASDAQ: CGIXHealthcare / Medical Laboratories & Research / USA
0.81-0.02-2.41%Vol 138 2101Y Perf -70.00%
Oct 16th, 2018 15:59
BID0.81 ASK0.85
Open0.82 Previous Close0.83
Pre-Market0.80 After-Trading-
 -0.03 -3.61%  - -%
Target Price
4.50 
Analyst Rating
Moderate Buy 2.00
Potencial %
455.56 
Finscreener Ranking
★+     44.83
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
+     33.20
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★+     38.74
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)22 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
0.37 
Earnings Date
8th Nov 2018

Today's Price Range

0.810.85

 

52wk Range

0.803.50

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-23.58%
3 Months
-5.81%
6 Months
-37.21%
1 Year
-70.00%
3 Years
-89.85%
5 Years
-95.15%

Quotes

Name / TickerPriceChg.Chg.%
CGIX0.81-0.0200-2.41
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.50
Current Ratio 0.70
Long Term Debt to Total Capital 0.03
Total Debt to Equity 0.60
Interest Coverage -6.10
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin34.70
EBIT Margin-50.40
EBITDA Margin-43.20
Pre-tax Profit Margin-127.80
Profit Margin-71.89
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.35
PS Ratios 1.05
Price to Cash Flow -
Price to Free Cash Flow -2.10
Cash Flow Per Share -0.58
Price to Tangible Book-5.47
Book Value per Share0.62
Enterprise Value (in ths.)32 002
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-62.27
ROE last 12 Months -91.52
Return on Assets (5Y Avg) -41.41
ROA last 12 Months -39.94
Return on Capital (5Y Avg) -46.14
ROC last 12 Months -52.51
Return on invested Capital Q -10.51
Return on invested Capital Y-55.43
Assets Turnover0.50
Receivables Turnover1.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)22 226
Revenue per Share 0.80
Revenue Growth 3 Years 13.72
Revenue Growth 5 Years 36.76
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.13-0.130.00
Q01 2018--0.16-
Q04 2017--0.35-
Q03 2017-0.13-0.16-23.08
Q02 2017-0.16-0.160.00
Q01 2017-0.18-0.1138.89
Q04 2016-0.22-0.1531.82
Q03 2016-0.28-0.2317.86
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.16-33.33Negative
12/2018 QR-0.13-44.44Negative
12/2018 FY-0.58-26.09Negative
12/2019 FY-0.1131.25Positive
Next Report Date8th Nov 2018
Estimated EPS Next Report-0.16
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume138 210
Shares Outstanding (in ths.)27 750
Trades Count269
Dollar Volume110 515
Avg. Volume332 673
Avg. Weekly Volume139 222
Avg. Monthly Volume268 590
Avg. Quarterly Volume160 943

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

52%48%

Bearish Bullish

66%34%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News

x